MA38878B1 - Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection. - Google Patents

Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection.

Info

Publication number
MA38878B1
MA38878B1 MA38878A MA38878A MA38878B1 MA 38878 B1 MA38878 B1 MA 38878B1 MA 38878 A MA38878 A MA 38878A MA 38878 A MA38878 A MA 38878A MA 38878 B1 MA38878 B1 MA 38878B1
Authority
MA
Morocco
Prior art keywords
hepatitis
prophylaxis
virus
treatment
tetrahydro
Prior art date
Application number
MA38878A
Other languages
French (fr)
Other versions
MA38878A1 (en
Inventor
Genadiy Kalayanov
Staffan Torssell
Horst Wähling
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Priority claimed from PCT/SE2014/051005 external-priority patent/WO2015034420A1/en
Publication of MA38878A1 publication Critical patent/MA38878A1/en
Publication of MA38878B1 publication Critical patent/MA38878B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés de formule : (i) dans laquelle b représente une nucléobase choisie parmi les groupes (a) à (d) et les autres variables sont telles que définies dans les revendications, lesdits composés étant destinés à être utilisés dans le traitement ou la prophylaxie d'une infection par le virus de l'hépatite c, et des aspects associés.The present invention relates to compounds of formula: (i) wherein b represents a nucleobase selected from groups (a) to (d) and the other variables are as defined in the claims, said compounds being for use in the treatment or prophylaxis of hepatitis c virus infection, and related aspects.

MA38878A 2013-09-04 2014-09-02 Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection. MA38878B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1351026 2013-09-04
PCT/SE2014/051005 WO2015034420A1 (en) 2013-09-04 2014-09-02 Hcv polymerase inhibitors

Publications (2)

Publication Number Publication Date
MA38878A1 MA38878A1 (en) 2018-06-29
MA38878B1 true MA38878B1 (en) 2018-12-31

Family

ID=63586945

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38878A MA38878B1 (en) 2013-09-04 2014-09-02 Novel 3-chloro-3-fluoro-tetrahydro-furan compounds inhibiting hepatitis c virus polymerase, useful for the treatment or prophylaxis of hepatitis c virus infection.

Country Status (1)

Country Link
MA (1) MA38878B1 (en)

Also Published As

Publication number Publication date
MA38878A1 (en) 2018-06-29

Similar Documents

Publication Publication Date Title
MA41338B1 (en) Pyrazine compounds for the treatment of infectious diseases
MA39721A (en) NEW CONDENSED HETEROARYLDIHYDROPYRIMIDINES IN POSITION 6 FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
MA46038A (en) SULFONIMIDOYLPURINONE COMPOUNDS SUBSTITUTED IN POSITION 7 FOR THE TREATMENT AND PROPHYLAXIS OF VIRAL INFECTION
MA41134A (en) 5-AMINO-6H-THIAZOLO [4,5-D] PYRIMIDINE-2,7-DIONE SUBSTITUTE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS
MA37942A2 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
MA42795A (en) USEFUL THERAPEUTIC COMPOUNDS FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF HIV VIRUS INFECTION
MA37712B1 (en) Macrocyclic inhibitors of flaviviridae virus
EA201691261A1 (en) NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS
MA39777A (en) ORGANIC COMPOUNDS OF THE MONOBACTAMS FAMILY FOR THE TREATMENT OF BACTERIAL INFECTIONS
MA39211B1 (en) Tricyclic compounds as anti-cancer agents
MA42410B1 (en) Oxysterols and their methods of use
EA201390538A1 (en) ANTI-VIRUS COMPOUNDS
MA35128B1 (en) Novel imidazole derivatives useful for the treatment of arthritis
MA35112B1 (en) Inhibitors of crude tyrosine kinase
EA201592126A1 (en) 6-BRIDGED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
MA32171B1 (en) Heterocyclic formulations
MA34896B1 (en) INHIBITORS OF HEPATITIS C VIRUS
MA37439A1 (en) Cyclic ether bridge dgat1 inhibitors for the treatment of acyl mediated disorders coa-diacylglycerol transferase 1 (dgat1).
EA201070422A1 (en) OXADIAZOL DERIVATIVES
MA38661A1 (en) Heteroaromatic compounds and their use as d1 dopamine ligands
MA31864B1 (en) ANTIVIRAL NUCLEOSIDE COMPOUNDS
MA33360B1 (en) Heterocyclic antiviral compounds
MA38675A1 (en) Derivatives of substituted 4'-fluoro-2'-methyl nucleosides useful for inhibiting the replication of hepatitis c (hcv)
MA41185B1 (en) Isoxazole hydroxamic acid compounds as lpxc inhibitors
MA38315A1 (en) Heterocycle-substituted tetracyclic compounds and methods for their use in the treatment of viral diseases